Lynn Wein Bush, PhD MSBioethics MA, is a Bioethicist-Developmental Scientist and Educator, earning degrees from Columbia University in Clinical Psychology, child & neuroscience subspecialty (PhD, MS, Internship and Fellowships); MSBioethics, and MA Developmental Psychology. This foundation, combined with Postgraduate courses in genomics, fetology, neuroscience and decades of experience in NICUs, PICUs, Pediatric specialty units, and MFM clinics informs her writings, research, and teaching on the ethical, psychosocial, scientific, and policy challenges of genomic testing and therapies along with other innovative technologies involving fetuses, newborns, infants, children, and women. Her focus is on the complexities, uncertainties, and contextual nuances posed during the prenatal-neonatal "developmental continuum", especially with rare disease, the "diagnostic odyssey continuum", inborn errors of metabolism, neurodevelopment disorders, and novel therapeutics.

Dr. Bush is Instructor in Pediatrics HMS, on faculty BCH Pediatrics, Genetics and Genomics, faculty HMS Genetic Training Program, affiliate faculty RSZ Translational Neuroscience Center, member BCH MFCC Fetal Therapy Board, member HMS Center for Bioethics, and The Academies at BCH and HMS. She is Collaborator to the YuLab on bioethical aspects of ASO individualized therapies and is Co-PI on an NIH ELSI R01 grant providing ethical guidance for the development genomic medicine as rare as n-of-1.